BRUSSELS: The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for early-stage Alzheimer’s disease, to be sold in the EU under strict conditions.The authorisation was granted Tuesday based on a favourable decision by Europe’s medicines watchdog, which after initial misgivings endorsed the treatment last November for a […]